Chemoinformaics analysis of 5-O-cafeoylquinic acid (5-CQA)
| Molecular Weight | 354.311 | nRot | 4 |
| Heavy Atom Molecular Weight | 336.167 | nRig | 15 |
| Exact Molecular Weight | 354.095 | nRing | 2 |
| Solubility: LogS | -1.198 | nHRing | 0 |
| Solubility: LogP | -0.162 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 43 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 1 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 6 |
| nHA | 8 | APOL | 45.9403 |
| nHD | 6 | BPOL | 21.5297 |
| QED | 0.234 |
| Synth | 3.871 |
| Natural Product Likeliness | 2.246 |
| NR-PPAR-gamma | 0.647 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.558 |
| HIA | 0.873 |
| CACO-2 | -6.127 |
| MDCK | 0.0000988 |
| BBB | 0.59 |
| PPB | 0.671863 |
| VDSS | 0.351 |
| FU | 0.340679 |
| CYP1A2-inh | 0.036 |
| CYP1A2-sub | 0.042 |
| CYP2c19-inh | 0.023 |
| CYP2c19-sub | 0.053 |
| CYP2c9-inh | 0.016 |
| CYP2c9-sub | 0.511 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.156 |
| CYP3a4-inh | 0.03 |
| CYP3a4-sub | 0.022 |
| CL | 3.251 |
| T12 | 0.928 |
| hERG | 0.014 |
| Ames | 0.026 |
| ROA | 0.028 |
| SkinSen | 0.156 |
| Carcinogencity | 0.059 |
| EI | 0.02 |
| Respiratory | 0.031 |
| NR-Aromatase | 0.108 |
| Antiviral | Yes |
| Prediction | 0.760491 |